Synthetic polypeptide adjuvant-antibiotic combination eradicates polymicrobial assemblies, dormant bacteria and

Swagatam Barman1, Md Waliullah Hossain2, Aiswarya Chandrasseril Bansidhar2

  • 1Department of Chemistry and Biochemistry, University of South Carolina, Columbia, South Carolina 29208, United States; Department of Environmental Health Sciences, University of South Carolina, Columbia, South Carolina, 29208, United States.

Biomaterials
|July 28, 2026
PubMed

Insights

Poly(D-peptide) (D-PP) adjuvants enhance antibiotic effectiveness against multidrug-resistant (MDR) Gram-negative bacteria. These combinations combat biofilms, dormant cells, and reduce resistance development, offering a new strategy for persistent infections.

Area of Science:

  • Microbiology
  • Drug Discovery
  • Biotechnology

Background:

  • Multidrug-resistant (MDR) Gram-negative bacteria pose a significant global health threat.
  • Treating complex infections involving biofilms, dormant cells, and polymicrobial communities remains challenging.
  • Novel strategies are needed to overcome existing antibiotic limitations.

Purpose of the Study:

  • To evaluate the efficacy of poly(D-peptide) (D-PP) as an adjuvant in combination with antibiotics against MDR Gram-negative bacteria.
  • To investigate the adjuvant's impact on bacterial biofilms, dormant subpopulations, and polymicrobial infections.
  • To elucidate the mechanisms underlying D-PP's synergistic effects and its role in preventing resistance.

Main Methods:

  • Combination therapy testing of D-PP with various antibiotic classes against planktonic and sessile bacteria.
  • Assessment of D-PP combinations against dormant bacterial subpopulations and polymicrobial cultures.
  • Biofilm eradication assays and transcriptomic analysis to identify differentially expressed genes (DEGs).

Main Results:

  • D-PP significantly potentiated antibiotic activity, leading to rapid bactericidal effects against planktonic Gram-negative pathogens.
  • Combinations restored antibiotic susceptibility in dormant bacterial subpopulations and reduced both Gram-negative and Gram-positive species in polymicrobial settings.
  • D-PP-rifampicin demonstrated moderate biofilm eradication of P. aeruginosa, and transcriptomic data indicated membrane perturbation as a key mechanism.

Conclusions:

  • Membrane-active polypeptide adjuvants like D-PP can enhance antibiotic efficacy against diverse bacterial states and environments.
  • These combinations offer a promising strategy to combat persistent and multidrug-resistant infections.
  • D-PP reduces bacterial resistance development to certain antibiotics, unlike polymyxin B.

Related Concept Videos

Biological Methods for Microbial Control01:28

Biological Methods for Microbial Control

Biological agents offer an effective means of controlling microbial growth by leveraging natural processes like predation, competition, and the secretion of antimicrobial substances.Predatory bacteria such as Bdellovibrio species target and kill pathogens like Salmonella and E. coli. They are widely used in poultry farms to control infections. Myxococcus species help combat plant-pathogenic fungi. These naturally occurring predators serve as eco-friendly alternatives to chemical pesticides and...
Biofilms01:29

Biofilms

Biofilms are complex communities of microorganisms encased in a self-produced extracellular polysaccharide matrix attached to surfaces. These microbial consortia can include single or multiple species, providing enhanced survival benefits by forming organized, multilayered structures.The formation of biofilms occurs through four key stages: attachment, colonization, development, and dispersal.During attachment, free-swimming planktonic cells adhere to a surface, often facilitated by...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Gene Regulation in Microbial Communities: Quorum Sensing01:28

Gene Regulation in Microbial Communities: Quorum Sensing

Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.